The temperature-programmed reaction of Co 3 Mo 3 N under H 2 /Ar results in a new nitride with composition Co 6 Mo 6 N. Powder neutron diffraction (PND) studies have confirmed unequivocally that the compound possesses the η-12 carbide structure, in which N atoms are exclusively located at 8a crystallographic sites, as opposed to the 16c sites exclusively occupied in the Co 3 Mo 3 N phase. On this basis, it possible to rationalize the observation that 50% nitrogen loss occurs under the hightemperature reduction conditions employed. Reaction of the reduced η-12 phase under N 2 /H 2 results in the regeneration of the η-6 Co 3 Mo 3 N nitride and return of nitrogen to the 16c sites (only). Although established for corresponding ternary carbide structures, the η-12 carbide structure is unprecedented in nitrides and a topotactic cycling between η-carbide structures is hitherto unknown. The ammonia synthesis activity of the η-6 nitride at ambient pressure and 400°C is 167 μmol g -1 h -1 , whereas the η-12 structure is unstable and reverts back to the η-6 structure under reaction conditions. Studies of the magnetic properties of the cobalt molybdenum nitrides demonstrate that both the η-6 and η-12 nitrides exhibit no long-range magnetic ordering and are superparamagnetic, although the coercive field (H c ) observed in magnetization measurements is diminished in the reduced nitride.
Lattice nitrogen within the catalyst Co(3)Mo(3)N is both reactive and likely highly mobile, enabling potential novel nitrogen transfer pathways; evidence suggests that loss and subsequent regain of lattice nitrogen in the system reversibly cycles through the previously unknown nitride, Co(6)Mo(6)N.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.